|
Betamethasone Composition: Dipropionate, Presentation: Associated With Betamethasone Phosphate, Dosage: 5Mg + 2Mg, Use: Injectable, Ondansetron Hydrochloride Dosage: 2, Indication: Injectable, Tenoxicam Dosage: 20, Meloxicam Concentration: 15, Pharmaceutical Form: Orodispersible Tablet, 04/17/2026 - 11:17:29, 17/04/2026 - 11:17:30, Diclofenac Presentation: Sodium Salt, Dosage: 25Mg/Ml, Use: Injectable Solution, Diclofenac Composition: Diethylammonium Salt, Concentration: 10, Pharmaceutical Form: Gel, Ketoprofen Concentration: 50, Pharmaceutical Form: Injectable Solution, Itraconazole Dosage: 100, Sodium Bicarbonate Composition: Associated With Citric Acid And Sodium Carbonate, Concentration: 462 Mg + 90 Mg + 438 Mg/G, Pharmaceutical Form: Effervescent Powder, Cyclobenzaprine Hydrochloride Concentration: 10, Additional: Orodispersible, Hydroxyquinoline. Composition: Associated With Trolamine, Concentration: 0.4 Mg/Ml + 140, Pharmaceutical Form: Otological Solution, Paracetamol Presentation: Associated With Codeine, Dosage: 500Mg + 30Mg, Dexchlorpheniramine Maleate Composition: Associated With Betamethasone, 4 Mg + 0.05, Pharmaceutical Form: Syrup, Fexofenadine Dosage: 120Mg, Benzydamine Hydrochloride Dosage: 3Mg, Sumatriptan Concentration: 50 Mg, Dipyrone Sodium Concentration: 1, Trometamol Composition: Ketorolac Salt, Pharmaceutical Form: Orodispersible Granules, Tobramycin Dosage: 0.3%, Presentation: Ophthalmic Solution, Ethyl Alcohol Environmental Cleaning Type: Ethyl, Application: Cleaning, Additional Characteristics: Liquid, Concentration: 70%, Carmelose Sodium Concentration: 5, Pharmaceutical Form: Ophthalmic Solution, Cloperastine Composition: Fendizoate Salt, Concentration: 3.54, Presentation: Syrup, Scopolamine Butylbromide Presentation: Associated With Dipyrone Sodium, Dosage: 10Mg + 250Mg, Orphenadrine Citrate Composition: Associated With Dipyrone And Caffeine, Dosage: 35Mg + 300Mg + 50Mg, Triamcinolone Composition: Acetonide Salt, Concentration*: 1, Pharmaceutical Form*: Oral Paste, Ketoprofen Concentration: 150, Pharmaceutical Form: Prolonged Release, Loperamide Hydrochloride Concentration: 2Mg, Pantoprazole Composition: Sodium Sesqui-Hydrate, Concentration: 20, Additional: Controlled Release, Flunarizine Dihydrochloride Dosage: 10, Aluminum Hydroxide Concentration: 60, Pharmaceutical Form: Oral Suspension, Ambroxol Composition: Hydrochloride Salt, Concentration: 6, Nystatin Presentation: Associated With Oxide Zinc, Concentration: 100,000Ui + 200Mg/G, Medication Type: Cream, Paracetamol Composition: Associated With Pseudoephedrine, Concentration: 500 Mg + 30, Probiotic Composition: Saccharomyces Boulardii - 17, Concentration: 200, Paracetamol Composition: Associated With Chlorpheniramine And Phenylephrine, Concentration: 400 Mg + 4 Mg + 4, Nimesulide Dosage: 100 Mg, Gel For Medical Examination Composition: Water Based, Application: Conductive, Additional Characteristics: Neutral Ph, Sterility: Sterile, Pharmaceutical Form: Topical Aerosol, Polymyxin B Composition: Associated With Neomycin And Hydrocortisone, Concentration: 10,000 Iu/Ml + 5 Mg/Ml + 10, Pharmaceutical Form: Otological Suspension, Salts For Oral Rehydration Composition: Sodium, Potassium, Chloride, Citrate And Glucose, Concentration: 50 Meq/L + 20 Meq/L + 50 Meq/L + 20 Meq/L + 134, Pharmaceutical Form: Powder For Oral Solution, Electrode Use Medical Application 1: For Electrostimulation, Physiotherapy, Model: Surface, Type: Adhesive, Sensor Material: Silver/Chlorinated Silver, Additional 1: With Conductive Gel, Dimensions: Diameter About 5, Accessory: With Cable Compatible With Equipment,
|
